Innovations that help you meet your patients needs

From access systems, through surgical stapling and vessel sealing technologies to implantable devices, we offer a comprehensive platform to take every element of a patient's health into careful consideration.

Surgical Stapling

Signia™ stapling system
 

Combines powered rotation, articulation and firing in a true one-handed design.1,* Automatically adjusts firing speed to optimise Tri-Staple™️ technology for most consistent results.2,3,** Displays real-time feedback about the forces on clamp and fire to support surgical decision making.4,†

EEA™ circular stapler with Tri-Staple™ technology

Circular stapling now comes with Tri-Staple™ technology. That means greater leak protection5,†,†† and greater perfusion allowed into the staple line.6,†††,**
 

GIA™ stapler with Tri‑Staple™ technology

The only open linear stapler available with the confidence of Tri‑Staple™ technology.

Vessel Sealing & Dissection

LigaSure™ XP Maryland Jaw Sealer/Divider With Nano-coating

Starting with the LigaSure™ XP Maryland, we’re adding new levels of performance, precision and procedural efficiency.7 Helping you meet the surgical demands of today and tomorrow. We’re excited to bring these expanded capabilities to our surgical energy portfolio — and we’re confident you will be, too.

LigaSure™ retractable l-hook laparoscopic sealer/divider

The functionality of five laparoscopic devices come together in one versatile instrument — with the reliable performance of LigaSure™ technology and Valleylab™ monopolar energy.10,‡‡

 

Sonicision™ 7 Curved Jaw Cordless Ultrasonic Device

The Sonicision™ 7 curved jaw ultrasonic dissector is a cordless device capable of coagulating and dissecting vessels up to and including 7mm in diameter.8

Access

VersaOne™ access system

Introducing the VersaOne™ access system, a universal trocar platform that gives you the performance, choice, and peace of mind in one complete solution.

The VersaOne™ fascial closure system

The VersaOne™ fascial closure system is a novel all-in-one device that serves as a trocar and fascial closure device to deliver consistent port site closure and suture placement.9,§

Hemostasis & Permacol™ surgical implant

Veriset™ hemostatic patch

The Veriset™ patch is designed to address the unmet need for a simple to use,10-12 fast and highly effective hemostatic patch.10-12

Allows hemostasis within approximately 1 minute.10,11,13,§§

Permacol™ surgical implant

The optimized Permacol™ surgical implant’s crosslinking enhances the durability without compromising biocompatibility, allowing tissue ingrowth and neovascularization compared to non-crosslinked acellular collagen implant.14-17,‡‡‡

Procedural kits

These products come packaged in a Procedure Box, that guarantees the right productsfor the right surgery at the right time.

With Procedural kits we offer you a solution that reduces:18

  • Preparation time of materials
  • Maximize efficiency in the OR
  • Support surgery standardization

References:

* 38 out of 38 surgeons surveyed agreed.

** Preclinical results may not correlate with clinical performance in humans.

† Benchtop test results may not necessarily be indicative of clinical performance.

†† Benchtop testing in porcine tissue ≤ 30 mm Hg (26 mm Hg average pressure experienced during intraoperative leak test), comparing TRIEEA31XT to Ethicon™* CDH29A (n = 20; P = 0.009).

††† Compared to EEA™ circular staplers with DST Series™ technology.

‡ Instances of tissue sticking to jaws measured over 110 seals per device.

‡‡ 29 out of 29 surgeons evaluated agreed

‡‡‡ Results may not correlate to performance in humans

§ Based on cadaver usability lab with 16 surgeons (13 of 16 surgeons agreed). The two devices are: a standard trocar and a fascial closure system. Preclinical results may not correlate with clinical performance in humans

§§ Based on surgeon/customer validation. In several clinical investigations, the median times to hemostasis were within 1 - 1.5 minutes

  1. Based on internal test report #RE00024826 rev D, Signia™ stapling system summative usability report. September 2016.
  2. Based on internal test report #R2146-173-0, ASA verification testing with slow speed force limit evaluation. 2015.
  3. Based on internal test report #R2146-151-0, Powered stapling firing speed DOE analysis and ASA parameters. 2015.
  4. Based on internal report #RE00055515, Sages Lab report. August 2016.
  5. Based on internal report #RE00318260, Comparative leak testing for EEA™ circular stapler with Tri-Staple™ technology and Ethicon™* CDH. April 2021.
  6. EEA™ circular staplers instructions for use
  7. Based on internal report #RE00457416 Rev A, Product introduction report: LigaSure™ XP Maryland jaw sealer/divider. May 2023.
  8. Based on internal test report #RE00329878 rev A, Marketing evaluation of surgeon experience using the Sonicision™ 7 curved jaw cordless ultrasonic dissector. Apr. 14–15 and 20-22, 2021.
  9. Based on internal validation report #RE00098009 Rev A, Double Time VersaOne™ fascial closure system Miami lab VOC (3/28). March 28, 2017
  10. Öllinger R, Mihaljevic AL, Schuhmacher C, et al. A multicentre, randomized clinical trial comparing the Veriset™ hemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery [published online Dec. 27, 2012]. HPB (Oxford). 2013;15(7):548-58. doi: 10.1111/hpb.12009.
  11. Schuhmacher C, Pratschke J, Weiss S, et al. Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleeding. Med Devices. 2015;8:167–174.
  12. Based on internal report #COVEULV0032, A Prospective, Multi-Center, Randomized, Single-Blind Study to Compare the Hemostatic Patch to Fibrin Sealant TachoSil™* in Subjects undergoing Hepatic Surgery, appendix B. January 2012.
  13. Glineur D, Hendrikx M, Krievins D, et al. A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleeding. Med Devices: Evidence and Research. 2018;11:65-75.
  14. N. J. Smart, N. Bryan, J. A. Hunt. A scientific evidence for the efficacy of biologic implants for soft tissue reconstruction. First published: 08 November 2012; Special Issue: Biologic Meshes in Colorectal Surgery. Volume 14, Issue Supplement s3, pages 1–6, December 2012.|https://doi.org/10.1111/codi.12042.
  15. Smart NJ, Bloor S. Durability of Biologic Implants for Use in Hernia Repair: A Review. Surg Innov, First Published December 4, 2011; 221 -229; https://doi.org/10.1177/1553350611429027.
  16. De Castro Brás LE, Proffitt JL, Bloor S, Sibbons PD. Effect of crosslinking on the performance of a collagen-derived biomaterial as an implant for soft tissue repair: a rodent model. Biomed Mater Res B Appl Biomater. 2010; 95:239-249*. Published online 28 September 2010 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/jbm.b.31704.
  17. Chand B, Indeck M, Needleman B, Finnegan M, Van Sickle KR, Ystgaard B, Gossetti F, Pullan RD, Giordano P, McKinley A. A retrospective study evaluating the use of Permacol™ surgical implant in incisional and ventral hernia repair. Int J Surg. 2014;12(4):296-303
  18. Procedural solutions box business case 16-weu-custom-procedure-kits-business-case-870893